HALT-C Patient Newsletters
HALT-C News is published and distributed to trial participants at various times throughout the year. Newsletters may be downloaded (PDF format) below.
October 2007
In this issue: Comments from HALT-C patients.
January 2007
In this issue:
- Hemochromatosis - Herb Bonkovsky, M.D.
- Herbal Supplements and Silymarin - Leonard Seeff, M.D.
- update on protease polymerase inhibitors - Mitchell Shiffman, M.D.
September 2006
In this issue:
- Dose Reduction - Mitch Shiffman, M.D.
- QLFTs - Greg Everson, M.D.
- Brief announcement on the HALT-C Extension - Leonard Seeff, M.D.
April 2006
In this issue:
- HALT-C Accomplishments and Future Directions - Andrea Reid, M.D.
- Quality of Life - Kristin Snow, Sc.D.
February 2006
In this issue:
- Portal Hypertension and Hepatitis C - Arun Sanyal, M.D.
- Development of New Treatments for Hepatitis C -Adrian Di Bisceglie, M.D.
- The Role of Liver Histology in the HALT-C Trial -Zack Goodman, M.D.
September 2005
In this issue:
- Hepatitis C and Alcohol: The Basics -Timothy Morgan, M.D.
- Use of Highly Sensitive Tests for Detecting Hepatitis C Virus in Serum - Chihiro Morishima, M.D.
- How to Beat Fatigue Caused by Hepatitis C - Elenita Rivera, R.N.
July 2005
In this issue:
- Hepatocellular Carcinoma - Richard K. Sterling, M.D. & Paula G. Smith, R.N., B.S.N.
- The Clinical Value of the Quantitative Liver Spleen Scan - John Hoefs, M.D.
- Hepatitis C and the Immune system - Implications for the HALT C trial - Alan Rothman, M.D.
- Featured Site: Virginia Commonwealth University
March 2005
In this issue:
- Hepatic Steatosis (Fat in the Liver) - Anna Lok, M.D.
- Mood and Brain Function in the HALT-C Trial - Robert J. Fontana, M.D.
- Impact of Cirrhosis on Response to Antiviral Treatment - Gregory T. Everson, M.D.
- Final Recruitment and Randomization Update - NERI
- Featured Site: University of Michigan
December 2004
In this issue:
- Good Nutrition and Hepatitis C - Yoon Park, R.N.
- Peginterferon Alfa-2a and Ribavirin in Patients With Chronic Hepatitis C Who Have Failed Prior Treatment - Mitchell L. Shiffman, M.D.
- Evaluation of studies of new chronic HCV treatments -- Mitchell L. Shiffman, M.D.
- Therapy for non-responders to pegylated interferon and ribavirin - Marc Ghany, M.D.
- Featured Site: NIDDK-Liver Disease Section
February 2003
In this issue:
- Get Hip to Hep-C! (Article on the rock band, Kelly's Lot)
- Initial Results From The Halt-C Trial Presented At Annual Liver Meeting - Karen L. Lindsay, M.D.
- Hepatitis Word Search puzzle
- Featured Site: University of Southern California
November 2002
In this issue:
- What about Pain-Relievers? Can I Take Tylenol? - William M. Lee, M.D.
- What Are They Doing With All My Blood and Liver Tissue? A Look at Ancillary Studies - William M. Lee, M.D.
- More Tips for managing side effects - Coordinators at Saint Louis University
- Featured Site: University of Texas Southwestern
June 2002
In this issue:
- Tips for managing side effects - Coordinators at Saint Louis University
- Liver Biopsy and the HALT-C Trial - Jules L. Dienstag, M.D.
- Featured Site: Massachusetts General Hospital
January 2002
In this issue:
- A Western MD's View of the Use of Herbs, Supplements, and Alternative Therapies By Patients with Hepatitis C. Excerpts from: Living with Hepatitis C: A Survivor's Guide, 3rd Edition, Hatherleigh Press, Inc. Copyright 2001 Gregory T. Everson and Hedy Weinberg
- Measuring Function Of the Liver (general overview QLFT) - Gregory T. Everson, M.D.
- Tips from Fellow Patients - Patients at UCHSC
- Featured Site: University of Colorado
October 2001
In this issue:
- How Do You Relax? Tips for Coping with Stress - SLU Coordinators
- HCV-RNA: What Is It And Why Do We Measure It? - Adrian M. Di Bisceglie, M.D.
- Match 'em Up! Game - SLU Coordinators
- Side Effects: Where Do They Come From? - SLU Coordinators
- Featured Site: Saint Louis University
July 2001
In this issue:
- Why the HALT-C Trial is a Prospective, Randomized, Controlled Trial -Herbert Bonkovsky, M.D.
- A Primer on Pegylation - Herbert Bonkovsky, M.D.
- What does the Liver Do? - UMASS Coordinators
- Love Your Liver Tips - from American Liver Foundation
- Featured Site: University of Massachusetts
April 2001
In this issue:
- Welcome HALT-C Participants - NERI
- HCV-RNA Viral Load and Testing. What does it all mean? - Mitchell Shiffman, M.D.
- What is a Non-responder? - NERI
- Who's Involved in the Halt-C Trial? (Listing of participating sites)
- About this Issue - NERI
- Featured Site: New England Research Insitutes